生物技术公司Vericel Corporation今日盘中股价大涨8.79%,最新报52.57美元/股,引发市场广泛关注。分析人士认为,公司强劲的最新财报业绩以及机构投资者的看好评级或是促成其当日大涨的主要原因。
最新季报数据显示,公司第三季度实现营业收入5791万美元,净利润虽仅-90.1万美元,但每股收益已转亏为盈,达到-0.02美元;而上一季度每股收益还为-0.26美元。公司财务数据向好逐步改善,令市场对其未来持续盈利增长预期。
同时,有权威分析机构调高了对Vericel的评级。数据显示,截至目前在7家参与评级的机构中,全部100%给予该股"买入"评级,无持有和卖出建议,体现了机构对其长期发展前景的积极乐观预期。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.